These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3131837

  • 1. Antagonism of PAF-induced death in mice.
    Myers AK, Nakanishi T, Ramwell P.
    Prostaglandins; 1988 Mar; 35(3):447-58. PubMed ID: 3131837
    [Abstract] [Full Text] [Related]

  • 2. Blockade of thromboxane and the prevention of eicosanoid-induced sudden death in mice.
    Darius H, Lefer AM.
    Proc Soc Exp Biol Med; 1985 Nov; 180(2):364-8. PubMed ID: 2996012
    [Abstract] [Full Text] [Related]

  • 3. Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation.
    Heinroth-Hoffmann I, Hauser A, Mest HJ.
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):181-2. PubMed ID: 2149184
    [Abstract] [Full Text] [Related]

  • 4. Antiaggregatory effects of thromboxane receptor antagonists in vivo.
    Darius H, Lefer AM.
    Thromb Res; 1985 Dec 01; 40(5):663-75. PubMed ID: 2935972
    [Abstract] [Full Text] [Related]

  • 5. Thromboxane agonism and antagonism in a mouse sudden death model.
    Myers A, Penhos J, Ramey E, Ramwell P.
    J Pharmacol Exp Ther; 1983 Feb 01; 224(2):369-72. PubMed ID: 6822961
    [Abstract] [Full Text] [Related]

  • 6. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ, Stewart AG.
    Br J Pharmacol; 1987 Apr 01; 90(4):771-83. PubMed ID: 3034369
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM.
    J Pharmacol Exp Ther; 1992 Apr 01; 261(1):131-7. PubMed ID: 1532833
    [Abstract] [Full Text] [Related]

  • 8. Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.
    Felsen D, Loo MH, Marion DN, Vaughan ED.
    J Urol; 1990 Jul 01; 144(1):141-5. PubMed ID: 2141654
    [Abstract] [Full Text] [Related]

  • 9. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P, Ambrosio G, Ragni M, Pascucci I, Triggiani M, Oriente A, McNatt J, Buja LM, Condorelli M, Chiariello M.
    Circulation; 1993 Sep 01; 88(3):1205-14. PubMed ID: 8353882
    [Abstract] [Full Text] [Related]

  • 10. Effect of platelet activating factor antagonists on cultured rat mesangial cells.
    Neuwirth R, Singhal P, Satriano JA, Braquet P, Schlondorff D.
    J Pharmacol Exp Ther; 1987 Nov 01; 243(2):409-14. PubMed ID: 3119816
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effect of thromboxane A2 and N-formylmethionylleucylphenylalanine on platelet-activating factor synthesis in human polymorphonuclear neutrophils.
    Kishino J, Hanasaki K, Kato T, Arita H.
    Biochim Biophys Acta; 1991 Apr 17; 1092(2):169-74. PubMed ID: 1673352
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of pulmonary thromboxane A2 synthase activity and airway responses by CGS 13080.
    McNamara DB, Harrington JK, Bellan JA, Graybar GB, Underwood DC, Kadowitz PJ.
    Mol Cell Biochem; 1989 Jan 23; 85(1):29-41. PubMed ID: 2725478
    [Abstract] [Full Text] [Related]

  • 13. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
    McColl SR, Krump E, Naccache PH, Poubelle PE, Braquet P, Braquet M, Borgeat P.
    J Immunol; 1991 Feb 15; 146(4):1204-11. PubMed ID: 1846895
    [Abstract] [Full Text] [Related]

  • 14. Effects of PAF and PAF antagonists on the shape of venous endothelial cells in vitro.
    Northover AM.
    Agents Actions; 1989 Aug 15; 28(1-2):142-8. PubMed ID: 2551151
    [Abstract] [Full Text] [Related]

  • 15. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep 15; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J, McGiff JC, Nasjletti A.
    Br J Pharmacol; 1989 Jan 15; 96(1):111-6. PubMed ID: 2522332
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.